Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 13 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 11098054

    Englerin derivatives for treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Sciences · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  2. US 11096927

    Anti-flavivirus compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  3. US 11098084

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  4. US 11091509

    HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  5. US 11084856

    Interleukin-4 receptor-binding fusion proteins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  6. US 11084850

    Recombinant prefusion RSV F proteins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  7. US 11078286

    Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  8. US 11077178

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  9. US 11066674

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  10. US 11066479

    Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  11. US 11065327

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  12. US 11060110

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  13. US 11059808

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  14. US 11058729

    Exosomes and miRNA to treat glaucoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  15. US 11053314

    Methods to eliminate cancer stem cells by targeting CD47

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  16. US 11040019

    Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  17. US 11041170

    Multivalent vaccines for rabies virus and coronaviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  18. US 11034736

    Anti-viral cnidarins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  19. US 11033620

    Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  20. US 11034740

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  21. US 11034757

    Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  22. US 11033621

    Combination therapies targeting tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  23. US 11027007

    Recombinant metapneumovirus F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  24. US 11027008

    Recombinant mumps virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.